Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 03.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 12.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 8-K are incorporated by reference herein. Item 5.02. Departure of Directors or Certain Officers; Election of Directors |
| 25.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C |
| 01.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 08.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Off |
| 23.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 20.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Unternehmen & Branche
| Name | Journey Medical Corp |
|---|---|
| Ticker | DERM |
| CIK | 0001867066 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 48115J109 |
|---|---|
| ISIN | US48115J1097 |
| Typ | Common Stock |
| Marktkapitalisierung | 138,3 Mio. USD |
| Beta | 1,04 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 61,858,000 | -11,431,000 | -0.47 | 94,589,000 | 31,852,000 |
| 2025-09-30 | 10-Q | 17,631,000 | -2,315,000 | -0.09 | 85,191,000 | 25,898,000 |
| 2025-06-30 | 10-Q | 15,009,000 | -3,796,000 | -0.16 | 81,158,000 | 19,246,000 |
| 2025-03-31 | 10-Q | 13,139,000 | -4,073,000 | -0.18 | 84,962,000 | 21,541,000 |
| 2024-12-31 | 10-K | 56,134,000 | -14,672,000 | -0.72 | 80,241,000 | 20,069,000 |
| 2024-09-30 | 10-Q | 14,629,000 | -2,390,000 | -0.12 | 64,044,000 | 10,926,000 |
| 2024-06-30 | 10-Q | 14,855,000 | -3,361,000 | -0.17 | 65,189,000 | 11,295,000 |
| 2024-03-31 | 10-Q | 13,030,000 | -10,442,000 | -0.53 | 66,571,000 | 12,951,000 |
| 2023-12-31 | 10-K | 79,181,000 | -3,853,000 | -0.21 | 76,849,000 | 20,350,000 |
| 2023-09-30 | 10-Q | 34,539,000 | 16,789,000 | 0.80 | 65,918,000 | 17,374,000 |
| 2023-06-30 | 10-Q | 17,172,000 | -8,363,000 | -0.46 | 69,747,000 | 5,000 |
| 2023-03-31 | 10-Q | 12,213,000 | -10,136,000 | -0.57 | 95,853,000 | 7,492,000 |
| 2022-12-31 | 10-K | 73,669,000 | -29,628,000 | -1.69 | 105,160,000 | 16,982,000 |
| 2022-09-30 | 10-Q | 16,116,000 | -10,080,000 | -0.57 | 108,145,000 | 26,184,000 |
| 2022-06-30 | 10-Q | 18,291,000 | -7,528,000 | -0.43 | 113,496,000 | 34,795,000 |
| 2022-03-31 | 10-Q | 23,296,000 | -1,378,000 | -0.08 | 120,901,000 | 41,438,000 |
| 2021-12-31 | 10-K | 63,134,000 | -43,994,000 | -4.32 | 97,284,000 | 42,043,000 |
| 2021-09-30 | 10-Q | 19,610,000 | -10,646,000 | -1.16 | 89,059,000 | -11,709,000 |
| 2021-06-30 | 10-Q | 15,288,000 | -11,865,000 | -1.30 | -792,000 | |
| 2021-03-31 | 10-Q | 10,719,000 | 268,000 | 0.02 | 10,767,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 1,316,275 | 0 | 1,316,275 | 10,148,480 | Neu | +100,0% | |
| Opaleye Management Inc. | 975,000 | 0 | 975,000 | 7,517,250 | Neu | +100,0% | |
| J. Goldman & Co LP | 798,366 | 0 | 798,366 | 6,155,402 | Neu | +100,0% | |
| VANGUARD GROUP INC | 764,147 | 0 | 764,147 | 5,891,574 | Neu | +100,0% | |
| BlackRock, Inc. | 719,784 | 0 | 719,784 | 5,549,535 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 457,812 | 0 | 457,812 | 3,529,731 | Neu | +100,0% | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 345,977 | 0 | 345,977 | 2,667,483 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 313,970 | 0 | 313,970 | 2,420,885 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 244,000 | 0 | 244,000 | 1,881,240 | Neu | +100,0% | |
| UBS Group AG | 390,138 | 290,226 | 99,912 | 1,829,747 | Aufgestockt | +34,4% | |
| AMERICAN FINANCIAL GROUP INC | 180,000 | 0 | 180,000 | 1,387,800 | Neu | +100,0% | |
| STATE STREET CORP | 173,337 | 0 | 173,337 | 1,336,428 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 109,351 | 0 | 109,351 | 843,096 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 93,669 | 0 | 93,669 | 722,188 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 69,415 | 0 | 69,415 | 535,189 | Neu | +100,0% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 67,442 | 0 | 67,442 | 519,978 | Neu | +100,0% | |
| Geneos Wealth Management Inc. | 63,280 | 0 | 63,280 | 487,889 | Neu | +100,0% | |
| LAZARD ASSET MANAGEMENT LLC | 62,525 | 0 | 62,525 | 482,068 | Neu | +100,0% | |
| Diametric Capital, LP | 51,683 | 0 | 51,683 | 398,475 | Neu | +100,0% | |
| PVG ASSET MANAGEMENT CORP | 51,632 | 0 | 51,632 | 398,082 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 51,270 | 0 | 51,270 | 395,293 | Neu | +100,0% | |
| Creative Planning | 50,510 | 0 | 50,510 | 389,432 | Neu | +100,0% | |
| STATE OF WISCONSIN INVESTMENT BOARD | 45,795 | 0 | 45,795 | 353,079 | Neu | +100,0% | |
| Integrated Wealth Concepts LLC | 44,020 | 0 | 44,020 | 339,396 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 35,507 | 0 | 35,507 | 273,759 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 27,819 | 0 | 27,819 | 214,484 | Neu | +100,0% | |
| MORGAN STANLEY | 26,500 | 0 | 26,500 | 204,315 | Neu | +100,0% | |
| BARCLAYS PLC | 22,521 | 0 | 22,521 | 173,637 | Neu | +100,0% | |
| Focus Partners Wealth | 19,710 | 0 | 19,710 | 151,964 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 19,401 | 0 | 19,401 | 149,582 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 19,203 | 0 | 19,203 | 148,055 | Neu | +100,0% | |
| Invesco Ltd. | 16,526 | 0 | 16,526 | 127,415 | Neu | +100,0% | |
| XTX Topco Ltd | 16,396 | 0 | 16,396 | 126,413 | Neu | +100,0% | |
| Neuberger Berman Group LLC | 15,951 | 0 | 15,951 | 122,982 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 15,748 | 0 | 15,748 | 121,417 | Neu | +100,0% | |
| SJS Investment Consulting Inc. | 15,000 | 0 | 15,000 | 115,650 | Neu | +100,0% | |
| Nuveen, LLC | 24,034 | 15,710 | 8,324 | 112,719 | Aufgestockt | +53,0% | |
| JANE STREET GROUP, LLC | 13,957 | 0 | 13,957 | 107,609 | Neu | +100,0% | |
| Atria Investments, Inc | 13,077 | 0 | 13,077 | 100,824 | Neu | +100,0% | |
| TITLEIST ASSET MANAGEMENT, LLC | 12,900 | 0 | 12,900 | 99,459 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,249 | 0 | 12,249 | 94,440 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 11,560 | 0 | 11,560 | 89,127 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 10,805 | 0 | 10,805 | 83,307 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 9,761 | 0 | 9,761 | 75,252 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 9,047 | 0 | 9,047 | 69,748 | Neu | +100,0% | |
| SALEM INVESTMENT COUNSELORS INC | 14,300 | 14,300 | 0 | 67,067 | Unverändert | 0,0% | |
| JPMORGAN CHASE & CO | 5,839 | 0 | 5,839 | 45,019 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 5,729 | 0 | 5,729 | 44,000 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 5,500 | 0 | 5,500 | 42,405 | Neu | +100,0% | |
| Tower Research Capital LLC (TRC) | 2,469 | 0 | 2,469 | 19,036 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-13 | 1.691 | 5,17 | 8.742 |
| 2026-04-10 | 3.585 | 5,19 | 18.606 |
| 2026-04-08 | 11.538 | 4,95 | 57.113 |
| 2026-04-06 | 2.475 | 4,95 | 12.251 |
| 2026-03-31 | 1.244 | 4,39 | 5.461 |
| 2026-03-27 | 105.365 | 4,78 | 503.645 |
| 2026-03-24 | 4.230 | 6,90 | 29.187 |
| 2026-03-18 | 180 | 7,50 | 1.350 |
| 2026-03-13 | 18 | 7,76 | 140 |
| 2026-03-02 | 123.800 | 8,17 | 1.011.446 |
| 2026-02-26 | 348 | 8,73 | 3.038 |
| 2026-02-18 | 3.147 | 8,10 | 25.491 |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| UBS Group AG | 390,138 | 1,829,747 | 89.51 |
| Nuveen, LLC | 24,034 | 112,719 | 5.51 |
| SALEM INVESTMENT COUNSELORS INC | 14,300 | 67,067 | 3.28 |
| Police & Firemen's Retirement System of New Jersey | 4,002 | 18,769 | 0.92 |
| Legal & General Group Plc | 1,801 | 8,447 | 0.41 |
| Russell Investments Group, Ltd. | 1,301 | 6,101 | 0.30 |
| Sterling Capital Management LLC | 134 | 628 | 0.03 |
| GAMMA Investing LLC | 101 | 474 | 0.02 |
| PNC FINANCIAL SERVICES GROUP, INC. | 41 | 192 | 0.01 |